Meet our Ambassadors 331 – 414

Jesutomisin Apara is a Medical Laboratory Science Intern at MedLabConvo in Nigeria. Jesutomisin is a biomedical science intern at Olabisi Onabanjo University Teaching Hospital (OOUTH), Nigeria. She is a member of Association of Medical Laboratory Scientists of Nigeria (AMLSN), African Society for Laboratory Medicine (ASLM), MedLabConvo. She has an interest in biomedical research, public health, education and advocacy in line with achievement of Sustainable Development Goal (SDG)s 3 & 4. She is a participant at Future Leaders against Antimicrobial Resistance (AMR) international programme which involves the development of students and early career professionals as future leaders in the work against AMR, where she is a lead member in the small mentorship project on “Understanding the trends in social AMR research and gaps in the field”. She is totally against guess-therapy and encourages proper laboratory testing and diagnosis prior to treatment of patients. She is passionate about exploring decentralized healthcare solutions for social impact and global relevance.

Raphael Hans Lwesya is Founder at The Phage in Uganda. He is young scientist, phage enthusiast, and passionate on driving the development of bacteriophage therapy and application to combat AMR. Founder of The Phage, an online hub for providing AMR updates and the possible alternative to antibiotic use. Raphael found the booming AMR cases in recent years to be of concern, hence decided to dig deep into Antibiotics promising alternatives.

Maria Ioana Onofrei is a teaching assistant within Infectious Disease Department of the Infectious Diseases Hospital “Sf. Parascheva” of the University of Medicine and Pharmacy “Grigore T Popa” Iasi, Romania. Maria is an infectious disease physician and clinical pharmacologist with experience in pharmacology, infectious disease and epidemiology. The long – term experience in clinical pharmacology offered her a valuable background for collaboration with other doctors and pharmacists to develop new protocols and to provide counseling for rational use of antibiotics. For her current medical practice as infectiologist, this activity was particularly challenging since it is well known that Romania is one of the countries with an increased AMR. On the other side, Maria is assistant professor in infectious diseases and epidemiology. Since she has to teach students from various countries (including students from Northern countries), it is her obligation to have enough knowledge in this field. Maria considers that a good knowledge about AMR, antibiotic stewardship programs and importance of multi-disciplinarity and sharing information mainly to young people is essential for awareness and application of measures that can save the entire ecosystem.

Roxanne Mohammed-Klein is an Infection Prevention and Control Support Lead Nurse at the North West London Integrated Care System in the UK. Roxanne has worked in the field of Infection Prevention and Control from more than 20 years. Her experience has been broad and varied and included working in large acute complex organisations as well as community. As a result she has had the opportunity to manage many outbreaks of multidrug resistant organisms and has seen the effects of these on patients as well as the organisation. Some of these had not been seen any where else in the world. Antimicrobial resistance has always been of interest to her since the start of her career and she believes that Infection Prevention and Control is fundamental in the prevention of the emergence of new antimicrobial resistant organisms and reducing transmission and spread. As an AMR Insights Ambassador she would like to contribute to raising awareness of the global threat and the implications to patients and to healthcare.

Maha Hoteit is Director and founder of PHENOL research group and coordinator of Lebanese University Nutrition Surveillance Center at LDFCA-Lebanese University in Lebanon. Maha Hoteit is professor and holding a PhD in Nutrition. She is the Director of the Master Program in Public Health Nutrition, the founder of the Public health Nutrition program of Lebanon (PHENOL) and the coordinator of Nutrition Surveillance Center at the Lebanese University. Her research interests lie in the area of public health nutrition, ranging from surveys, to clinical trials than to policies implementation. In recent years, she has focused on studying the effect of nutritional interventions on health community’s outcomes by spreading the term “Public Health Nutrition”. More than 35 publications observed lights between 2014 and 2021 aiming to improve the quality of life of communities living in Lebanon. Main topics were non-communicable diseases, food composition data, food security, infant nutrition, antimicrobial resistance in milk products and mycotoxins in Lebanese foods. Some of the research projects were achieved in collaboration with the Regional office of the World Health Organization.

Kim Hardie is a a Professor in Bacterial Pathogenesis at the University of Nottingham in the United Kingdom. She focuses on the research of novel antimicrobial targets and characterizes molecular mechanisms of antimicrobial resistance in bacterial communities (biofilms). Kin co-directs the Doctoral Training programme in Antimicrobials and Antimicrobial Resistance held jointly between University of Nottingham and University of Birmingham, funded by the Welcome Trust. Kim is also involved in the research of novel antimicrobial targets and AMR.

Landry Beyala B. is a Research Laboratory Manager at the M.A. SANTE (Meilleur Accès aux soins de Santé Cameroun) in Cameroun. Landry is passionate about Microbiology and Molecular Biology Research. He holds of a Master’s Degree in Clinical Biology obtained from the University of Dschang-Cameroon whose work focused on the profile and antibiotic susceptibility pattern of bacterial pathogens associated with diarrhea. He is currently working on a project that aims to understand the magnitude and kinetics of the serological responses to killed oral cholera vaccine when given 2 to 3 years after an initial receipt. Previously, he seeked to understand the Extended Dose Intervals With OCV in Cameroon ; this project was to determine changes in the vibriocidal geometric mean titers in subjects who receive the second dose of OCV at different intervals: 2 weeks, 6 months, or 11 months following the first dose of vaccine. His work experience for the past five years has focused on microbiology, Immunology, cholerae surveillance, clinical trial of Oral Cholera Vaccine, ARM, and Quality Assurance.

Carla Brown supports digital content and serious game content developed by AMR Insights. She is director at Game Doctor Ltd in the UK. Her background is in scienceited.com and health education. Carla completed her PhD in microbiology at University of Glasgow and then completed her postdoc in health gamification at Drexel College of Medicine. From there Carla moved to Public Health England, developing gamified interventions around infectious disease prevention. In 2017, inspired by the field and my dedication to promote positive change, she set-up Game Doctor, a gamification agency serving the health and research industry. Her work has been recognized by Forbes 30 under 30 and Herald Higher Education Awards.

Praveen Rai is Associate Professor at NUCSER in India. Praveen Rai has a PhD (Molecular Virology) from Karnataka Veterinary, Animal and Fisheries Sciences University, Bidar. He joined NUCSER in 2014. He has 36 research publications in highly rated journals of international standard, mostly related to molecular characterization of microbial pathogens. Currently, his research focuses on molecular characterization of Dengue and Rotaviruses, development of point of care diagnostics for SARS-CoV-2, Dengue virus, Human Papillomavirus (HPV), Malaria Parasite and Leptospira, Screening of antiviral compounds, Host-Pathogen Interaction, RNA Interference and Phage based biocontrol technologies. His research work is supported by various agencies such as SERB, DST, DBT, ICMR and Nitte (DU).

Ramsha Syed is a Public health professional at the Health Services Academy in Pakistan. Ramsha is working for different causes in the community. She is a medical doctor by profession and focused on prevention of antimicrobial resistance. She has conducted campaigns and webinars regarding AMR and is working actively for that. She is also looking forward to new opportunities and researches related to antimicrobial resistance.

Ahmad Hussen Tareq is the Technical lead AMR in Pakistan. He is an AMR expert and has a PhD in AMR with the breakthrough discovery of teixobactin from MIT-US, NTU-SG, advising LMIC and developed countries in developing AMR related technologies and physicians specific AMR training nationwide. He advised the government of Pakistan in the AMR National Action Plan development and donor finding related activities. Ahmad is also leading the AMR rated initiative in Pakistan for awareness and advocacy in the nation of 232 million people.

Jimmy Nkaiwuatei is an AMR Researcher at Students Against Superbugs Africa in Kenya. Jimmy is the Head of Drug Research, Discovery and Innovations program at Students Against Superbugs Africa. He has been engaging students in drug research and development programs across Africa. Through this program he aims at training students and introduce them to the processes involved in drug research and development with a view to learn and innovate effective solutions against Antimicrobial resistance.
This involves tertiary level students as well as the early career developers.
He saw there is a dire need to innovate new alternative therapies against the Antimicrobial resistant microorganisms and students can play an important role in bringing together consolidated efforts towards AMR mitigation. Students are our future leaders, policy makers, researchers and health care providers. Therefore, it is quite imperative to engage them in this fight against this global health threat.

Sylvia Dreyer is a Scientist at the Institute of International Animal Health/ One Health at the Friedrich-Loeffler-Institut (FLI), Germany. Her institute was newly founded in 2020 and is the primary point of contact to FLI for international organizations as well as other ministries of the German administration in relation to animal health and international cooperation. The overall goal is to assist in the control and eradication of transboundary animal diseases (TADs) and zoonoses where they currently circulate, and therefore contribute to protect non-infected countries or regions from the incursion. In close cooperation with a colleague from another FLI institute, Sylvia focuses on supporting non-European countries to implement their NAP on AMR by improving AMR surveillance. The long-term goal is to establish solid One Health surveillance systems with the help of capacity building, e.g. lab training, and the joint evaluation and improvement of local monitoring systems.

Vipula Tailor, founder & CEO of Sonix Medical Devices in the USA, is a microbiologist and immunologist by training.  She is a seasoned pharmaceutical and medical devices executive and entrepreneur with over 20 years of international business development, licensing, R&D, and commercialization experience in biotech, pharmaceuticals, medical devices/diagnostics, and healthcare areas. Passionate about improving patient health and developing holistic medical solutions, providing access to medicines and quality care, and fostering sustainable innovations. She has developed an innovative technology platform that will help prevent and treat infections without the need for antibiotics. Sonix -A8 is a novel and patented non-invasive technology platform to prevent bacterial infections and combat Antimicrobial Resistance (AMR) without the use of antibiotics. ‘Sonix-A8’ is a breakthrough technology platform that prevents and controls Surgical Site Infections (SSI’s) and Hospital Acquired Infections (HAI’s). This technology kills bacteria, including superbugs like MRSA, and is effective on and below the skin surface, where traditional treatments can’t reach.  Sonix-A8 technology platform completely destroys biofilms and combats AMR.

Nurudeen Salisu is the Executive Director at the Centre for Community Advancement and Development in Nigeria. Nurudeen is a Laboratory Technologist working with the Department of Microbiology, Federal University Gusau, Nigeria and founder of Centre for Community Advancement and Development, an NGO working to fight against antimicrobial resistance and climate change. As part of his public health advocacy against the menace if antimicrobial resistance, he works to create awareness to members of his communities and colleagues. Nurudeen is actively been involved in partnership with both government agencies and other non- governmental organizations in designing programs, supporting operations and managing programs related to antimicrobial resistance in Northwestern Nigeria.

Waqas Ahmad is Assistant Professor at the University College of Veterinary and Animal Sciences, Narowal Campus in Pakistan. Waqas has been working as an Assistant Professor in the discipline of Epidemiology and Public Health at the University College of Veterinary and Animal Sciences-Narowal, Pakistan for the past 5 years. His areas of expertise include the research of bacterial and viral zoonotic diseases in one health paradigm, especially the animal-human and science-policy interface. Some of the salient diseases include rabies, brucellosis, tuberculosis, and the associated public health concerns of AMR. Waqas has presented his research and work through nominated conferences, workshops, pieces of training, and webinars in several national and international forums of public health domains.

Shahzeb Javed is a Student/ Research Assistant at the Abbottabad University of Science and Technology in Pakistan. Shahzeb is a Master student at the Department of Microbiology at the Abbottabad University. Currently, he is working as a Research Assistant in the Higher Education Commission Project Use of Bacteriophage for controlling Citrus Canker caused by Xanthomonas Citri. He is trying to resolve the biggest issue Antimicrobial resistance through Bacteriophage therapy. In his opinion, self-medication is the biggest reason in developing countries to spread Antimicrobial resistance.
Shahzeb would be happy to be connected for future collaborations.

Collins Ankunda is a clinical researcher at Mildmay Uganda in Uganda. Collins is a palliative care specialist and a clinical researcher with a bias in vaccine and drug development. Collins is personally interested in evaluating health service delivery systems that accelerate AMR and create awareness among front line health care workers on the same. He has over 10 years experience in HIV/TB/STI prevention care and treatment a at both implementation and supervisory levels.

Ghada Zoubiane is Head of partnerships and Stakeholder engagement at the International Centre for AMR solutions (ICARS) in Switzerland. In her role, she is shaping and delivering on ICARS’ mission, bridging the gap between evidence and practice, and working in close partnership with low- and middle-income countries. She is developing collaborations with a wide range of stakeholders including potential donors, UN bodies, NGOs and the private sector. With a strong appreciation of the science/policy interface, her role includes outreach and advocacy, as well as advising on ICARS strategy. Ghada has over 20-year experience in both the public and private sector leading and executing research strategies at a national and international level. She was previously the Science and Innovation Lead on AMR at Wellcome, shaping and delivering on their strategy. In addition, she spent over nine years at the UK Medical Research Council (MRC) developing different areas of research including AMR, infectious diseases and public health.

Rit Shrestha is working as the Vice President and Director of Member Education at Alliance Against AMR in Nepal. Rit is an avid learner of the causes and repercussions of antibiotic resistance and an equally enthusiastic, resolute warrior in the fight against the factors that have led to the rise of superbugs. As an educator in several awareness programs as well as an active member of the organizing committee for various conferences and national events, she has garnered varied experiences and is always open to new learning opportunities.

Iyiola Oladunjoye is a One Health Research Coordinator at the Rouleaux Foundation in Nigeria. Iyiola is a microbiologist and One Health Research Coordinator at Rouleaux Foundation, a nonprofit organization that aims to promote science for sustainable development in Africa. As a microbiologist, Iyiola has gained extensive work experience across the spectra of environmental, human and animal health. Iyiola is an aspiring biomedical scientist with the goal of creating sustainable solutions to Antimicrobial Resistance through research geared towards providing novel therapeutics or diagnostics methods in identifying resistant pathogens. Iyiola is currently the American Society for Microbiology (ASM) Young Ambassador to Nigeria, and doubles as a member of the Young Leaders Circle, an advisory board group on youth and society. He was also a fellow of the One Health Advocacy and Mentorship programme in Nigeria. He is passionate about science literacy and young engagement in science, leadership and governance.

Augustine Odibo is an early career researcher and Founder of
PharmahubNG in Nigeria. Augustine is a graduate of Pharmacy.Bpharm, PharmD Nigeria. He is passionate about curbing the fast rise of antimicrobial resistance. He has done this in his pharmacy practice by ensuring that antibiotics are only dispensed when necessary and with prior test. He has recently completed a course on Antimicrobial stewardship which equiped him with the knowledge and methodology he applies to this day in administering antimicrobial treatments. He recently began a research to discover the extent of antimicrobial resistance, alongside other career researchers in his state on how to prevent and curb the super-bug. He is of the belief that bacteria are communal and antimicrobial resistance might be contagious, in the sense that people living together might be resistant to the same bacteria. He looks forward to future studies and research to help develop new methods / treatments for antimicrobial control and to lead such research in the near future.

Ejiofor Chizoba Victor is a 400L student of Pharmacy at the University of Nigeria citadel of learning in Nigeria. He is interested in helping people lead a better life free of health risks, and in researching to enrich knowledge. He has obtained certification in human resource management from a qualified professional body to further broaden his knowledge in Management of people.

Ngere Daudi is a Medical Laboratory Technologist at the Kisii University in Kenya. Ngere is a passionate student of antimicrobial resistance. He has been attending webinar series on Antimicrobial resistance organized by US CDC. Ngere is currently doing research on Antimicrobial Resistance of Staphylococcus aureus in patients attending Provincial General Hospital, Nakuru Kenya. His work is focused on identification of AMR patterns of S. aureus which will help in the long run reduction of resistant S. aureus strains. The research will also contribute to the identification and advisory of effective drugs against S. aureus in a hospital set up. Through the research, the data will help in the realization of the extent of AMR of S. aureus and thus creating awareness to the public, health sectors, policy makers and other stakeholders.

Mabel Ortiz De Leo is a Master in Science in AMR student at the University of Sheffield in the United Kingdom. Mabel is a Mexican Medical Doctor with ample experience in infectious diseases. Since she was in medical school she became interested and involved in public health research specifically in sexually transmitted diseases and HIV. After graduating she started working in the healthcare setting in which she realized the abuse of antimicrobials was becoming a major problem not only in her country but worldwide. She is finishing an Msc in Antimicrobial Resistance and doing research on a possible new mechanism for AMR by studying the cryptococcus neoformans heteroresistance mechanisms to fluconazole. She expects this will have an impact on the treatment of cryptococcal meningitis and other neglected tropical diseases that are common in immunocompromised patients. The focus of her future work is on understanding how antimicrobial resistance mechanisms evolve in immunocompromised patients with a specific focus on LMIC’s, in which fungal diseases are most prevalent.

Bright Obi is a member of the Resistant Infection Research Group, University of Nigeria, Nsukka in Nigeria. Bright is a highly motivated young scientist who holds a Bachelors degree in Microbiology from the University of Nigeria Nsukka, Nigeria. As an early career researcher, his interest in Antibiotic Resistance led him to becoming an active member of Resistant Infections Research Group, University of Nigeria Nsukka, so as to understudy the underpinnings of Antibiotic Resistance. His undergraduate thesis focused on Antibiotic Resistance of E. coli to Beta-Lactam antibiotics. He has a track record of volunteering in different public health outreaches, educating his community and sharing epidemiological insights. He eagerly looks forward to collaborations and exciting opportunities.

Emmanuel Elebesunu is a Medical Journalist at the University of Nigeria, Nsukka in Nigeria. As a Medical Laboratory Science Student, his specialty is Medical Microbiology and Antimicrobial Resistance (AMR) is one of his research interests. As a Medical Journalist and AMR Control Advocate, he has been involved in Panel Discussions on AMR in Africa, spoken and presented research abstracts related to AMR in various scientific conferences, written articles on AMR published in various blogs and magazines, and worked on two scientific research papers on AMR Challenges in Malaria and Gonorrhoea (of which one published and the other undergoing peer review in an international journal). Emmanuel also happens to be affiliated with 2 AMR Organizations, which are the British Society for Antimicrobial Chemotherapy (BSAC) and Students Against Superbugs Africa (SAS Africa), where we work towards improving public awareness about AMR and proffering solutions to AMR in Africa.

Vidya Bhardwaj is a Microbiology Veterinarian at the City University of HK Veterinary Diagnostic Laboratory in Hong Kong. As the microbiology veterinarian of a veterinary diagnostic laboratory, she manages all aspects of sensitivity testing. She uses tests and results to produce reports on surveillance data in Hong Kong as well as develop programs that drive better antimicrobial stewardship in veterinary clinics in Hong Kong. Vidya oversees surveillance programs for AMR in livestock farms in Hong Kong.

Saffiatou Darboe is a Microbiologist and Researcher at the Medical Research Council Unit at LSHTM in Gambia. Saffiatou is a dedicated and vision-driven Medical Microbiologist with extensive experience in the management of Medical Laboratory Sciences. She has a special interest in strengthening diagnostic microbiology capabilities to improve antimicrobial stewardship and antimicrobial resistance (AMR) surveillance. Most importantly, she leads and coordinates a dynamic collaboration between the MRCG at LSHTM and UCLA, California for the improvement of diagnostic capabilities in The Gambia. She is a postgraduate researcher focused on antimicrobial resistance. Saffiatou is also the current Young Ambassador of American Society for Microbiology (ASM) to The Gambia. Enthused about public engagement and communicating science activities.

MaryTheresa Chinaza Akwue is a student at the University of Nigeria Nsukka in Nigeria. Mary is a graduate of Zoology and currently a student of Pharmacy at the University of Nigeria Nsukka. A pharmacy student with an interest in public health and personal development, open to learning and love volunteering to any health related work/organisation to help educate the people and also improve healthy living, to help curb some of the health challenges that we do face, out of ignorance. This inspired my joining the AMR Insights Ambassador Network, to help educate the people on the knowledge of AMR and also tackle the challenges faced due to AMR.

Abdullahi Aborode is a Research Director at the Healthy Africans Platform in Nigeria. Abdullahi is a global health and evironmental advocate, Harm Reduction Scholar in Germany, Royal Society of Tropical Medicine and Hygiene Student Ambassador, WHO antibiotics guardian, drug policy and harm reduction advocate and health researcher with more than 50 publications in international peer reviewed journals such as SAGE, Elsevier, Taylor and Francis, Havard Public Health Review, American Journal of Tropical Medicine and Hygeine etc. In addition, he assumes the professional role of Director for research in SWIS Africa Research Hub, Oli Health Magazine Organization, Healthy Africans Platform, and Brain Builder Youth Development Initiatives.

Rotimi Jaiyesimi is a Group Associate Medical Director for Patient Safety at the UK National Health Service & Consultant in Obstetrics and Gynaecology at the Mid and South Essex University Hospitals NHS Foundation in the United Kingdom. He works with the clinical governance team to ensure effective antimicrobial stewardship, minimising drug resistance and the incidence of C. difficile and MRSA infections. He was the Lead for Sepsis Management. He is a member of USA Patient Safety Movement Working Group on Sepsis. He is Consultant Obstetrician and Gynaecologist and Visiting Professor of Law (medical law). He has published extensively and is an international speaker. He is mindful of the global threat of antimicrobial resistance and will collaborate with organisations and national governments to combat AMR. He believes low- and medium-income countries must not be left behind and is currently exploring collaborations that will strengthen the role of pharmacists in AMR. He is committed to making an impact in addressing these issues as an ambassador for antimicrobial resistance.

Paola Roncada is an Associate Professor at the University Magna Græcia of Catanzaro Department of Health Sciences in Italy. The results of Paola’s research activity are reported in more than 90 publications in international journals with anonymous review (peer review), H index is 32 (Google scholar 30.09.2021). Over the years, Paola has been particularly dedicated to studies of proteomics, a discipline that she has applied to the study of One Health approach, in particular on microorganisms in the veterinary public health sector, applying advanced molecular methodologies to the etiopathogenetic and diagnostic study of diseases of medical-veterinary interest, even in animal models. She also applied proteomics by investigating phenotypic adaptations of microbial consortia in complex matrices, both animal and food of animal origin. She is involved in different international and national projects, as ERA NET, COST ACTIONS, AND EU KBBE. From 2019 she is President of Italian Proteomics Association (ItPA) and from 2016 she is Council member of Human Proteome Organization (HUPO).

Musa Abba Mohammed is a Public Health Consultant at the PharmAccess Foundation in Nigeria. A Public Health Professional with skills in program management, capacity building, public-private partnerships, advocacy, and field coordination. He has experience implementing health system strengthening, humanitarian response, and WASH programs. He holds a Masters in Health Planning and Management and BSc. (Hons.) in Microbiology from the University of Maiduguri, as well as a Master of Public Health (MPH) from the University of Chester. As part of his thesis, he conducted a systematic review and meta-analysis on The Effectiveness of Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine for Malaria in Pregnancy. Musa lately worked as the Program Manager under the Nigeria State Health Investment Program (A World Bank-supported Performance-Based Financing Intervention) and currently works as a Private Sector Engagement Consultant under the USAID Integrated Health Program. With rising antimicrobial resistance globally, Musa is passionate and committed to being part of the Army of Antimicrobial Resistance Fighters, wherever, whenever, and however.

Audrey Rollin is AMR Mission Special Projects Officer at CSIRO in Australia. Part of her role is to investigate existing AMR and AMU surveillance systems across the One Health spectrum, globally and nationally. Prior to CSIRO, Audrey was at the University of Technology Sydney as Project Officer of the OUTBREAK project focusing on One Health AMR surveillance. Previously, Audrey has held communications and marketing roles in the health and research sectors since 2016, both in Europe and Australia. She recently completed a PhD in digital health and biomedical informatics.

Branwen Morgan is AMR Mission Lead at CSIRO in Australia. Branwen is leading an initiative at Australia’s national science agency to build and co-create an AMR Mission with external stakeholders across government, industry and other research organisations. Over the last twenty years, Branwen has held numerous senior communications, strategy, and project delivery roles that bridge academic organisations, publicly listed companies, government and NGOs in the UK and Australia. She has a PhD in medicine and has previously worked as a science journalist. Most recently, Branwen was at the University of Technology Sydney where she was co-founder and managing director of the OUTBREAK project focusing on One Health antimicrobial resistance surveillance.

G Srinivasa Rao graduated in Veterinary Science and did post-graduation and doctoral degrees in Veterinary Pharmacology and at present working as Professor of Veterinary Pharmacology & Toxicology, Sri Venkateswara Veterinary University, Andhra Pradesh, India. Antimicrobial resistance is spreading like pandemic and may be another cause for heavy human loss in coming years in the world. Use of antibiotics either therapeutic or non-therapeutic purpose in animal and aquaculture production is one of the established causes for the AMR globally. Searching for natural products as alternatives for antibiotics in animal production can be viable option to reduce antibiotic load in animal production. Developing delivery systems for natural products in vivo is key aspect to be addressed in coming years for the success of containing AMR spread further in animal production systems. Let us fight collectively and globally to come out of the AMR for better living in the world.

Prabhakar Maurya works as a Toxicologist at Consultancy for Environmental & Human Toxicology and Risk Assessment (CEHTRA), at its India Office. He is a veterinarian by training and has >5y of experience working at interface of sustainable development and policy issues in fields of climate change, public-health, agriculture, food science, AMR and animal health sector. He is on consultancy board of GLG, USA and National member of Indian Initiative for Management of AMR.

Vijay Pal Singh is veterinarian at the CSIR-Institute of Genomics and Integrative Biology in India. Vijay is a veterinarian by training and worked on the regulatory and surveillance aspect of Anti Microbial Resistance in Food Safety and the Standard Authority of India. Now he is researching the antimicrobial use misuse and overuse and resistance pattern in milk and milk products. He is very passionate to bring change in Antimicrobial Resistance through evidence. He played a pivotal role in banning the import of colistin and its usage in food animals.

Veranja Liyanapathirana is a Educator and Researcher at the University of Peradeniya, Sri Lanka. Veranja is a lecturer in Microbiology at a Medical School in Sri Lanka. She is medically qualified but has completely switched to teaching and research. Initially, she was “attracted” to antibiotic resistance as this was an “emerging field” back in the days when she started off Microbiology. Her main interest those days were to identify resistance patterns and genetics behind it. However, with time she has realized that no matter how much we study the genetics of resistance or epidemiology, unless there is tangible action by humankind collectively, this issue is not going to be addressed. Right now she is more interested in trying to see how the available “data” can be converted to “action” at the grass-root level.

Avis Nowbuth is final year medical student at the Pan-African Organization for Health, Education and Research in Zambia and founder of AMR_Africa. Avis is a medical researcher located in Lusaka, Zambia. Her main clinical and research interest is addressing antimicrobial resistance and strengthening antimicrobial stewardship in low-resource settings, specifically in improving compliance and management antibiotics; and addressing misuse and inappropriate use of drugs for infectious diseases. She has since founded a program, I AMResponsible (Twitter: @AMR_Africa) that addresses and encourages young professionals to tackle this approach using a multidisciplinary approach.

Desislava Vankova is University teacher and researcher at the Medical University of Varna, Bulgaria. Desislava is a Medical Doctor with more than 25 years of experience in healthcare. She is Master of Public Health (Maastricht University, Netherlands) and she has a PhD in social medicine and healthcare organisation. Since 2017 she is Associate Professor at the Medical University of Varna. Docent Vankova is teaching social medicine, public health, epidemiology etc. Her particular research interests include epidemiological and clinical studies, health-related quality of life and well being, health promotion interventions, bioethics, integrative and complementary medicine, concept development and mixed-methods research. Regarding AMR (antimicrobial resistance), Desislava is interested in the role of Traditional and Complementary Medicine (T&CM) as an effective and efficient way to reduce inappropriate antibiotic use (delayed prescription strategies) or as alternative prevention or treatment. She is member of the European Public Health Association (EUPHA) and the European Society of Integrative Medicine (ESIM).